Search

Your search keyword '"Brooks, Oliver"' showing total 13 results
Start Over Author "Brooks, Oliver" Publisher u.s. government printing office
13 results on '"Brooks, Oliver"'

1. Use of COVID-19 Vaccines for Persons Aged [greater than or equal to] 6 Months: Recommendations of the Advisory Committee on Immunization Practices-United States, 2024-2025

Author

Panagiotakopoulos, Lakshmi, Moulia, Danielle L., Godfrey, Monica, Link-Gelles, Ruth, Roper, Lauren, Havers, Fiona P., Taylor, Christopher A., Stokley, Shannon, Talbot, H. Keipp, Schechter, Robert, Brooks, Oliver, Daley, Matthew F., Fleming-Dutra, Katherine E., and Wallace, Megan

Subjects
Vaccination -- Usage, Drug approval -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Pfizer Inc., United States. Food and Drug Administration
Abstract

On Tuesday, September 10, 2024, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Introduction COVID-19 continues to account for thousands of hospitalizations and hundreds [...]

Published
2024

2. Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged [greater than or equal to]65 Years: Recommendations of the Advisory Committee on Immunization Practices--United States, 2024

Author

Panagiotakopoulos, Lakshmi, Godfrey, Monica, Moulia, Danielle L., Link-Gelles, Ruth, Taylor, Christopher A., Chatham-Stephens, Kevin, Brooks, Oliver, Daley, Matthew F., Fleming-Dutra, Katherine E., and Wallace, Megan

Subjects
United States. Department of Health and Human Services, Pfizer Inc., Epidemics -- United States, Vaccination -- Usage -- Health aspects, Public health -- Health aspects -- Usage, Adults -- Health aspects -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Health aspects -- Usage, Health
Abstract

Introduction Since June 2020, CDC's Advisory Committee on Immunization Practices (ACIP) has convened 39 public meetings to review data and consider recommendations related to the use of COVID-19 vaccines (1). [...]

Published
2024

3. Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices--United States, 2023

Author

Kidd, Sarah, Clark, Thomas, Routh, Janell, Cineas, Sybil, Bahta, Lynn, and Brooks, Oliver

Subjects
Vaccination -- Usage, Neomycin -- Usage, Paralysis -- Usage, Adults -- Usage, Epidemiology -- Usage, Poliomyelitis -- Usage, Vaccines -- Usage, Health
Abstract

Introduction Poliovirus infection can cause poliomyelitis and permanent paralysis. The incidence of paralytic polio in the United States decreased rapidly after introduction of the Salk inactivated poliovirus vaccine (IPV) in [...]

Published
2023

4. Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged [greater than or equal to] 6 Months: Recommendations of the Advisory Committee on Immunization Practices--United States, September 2023

Author

Regan, Joanna J., Moulia, Danielle L., Link-Gelles, Ruth, Godfrey, Monica, Mak, Josephine, Najdowski, Morgan, Rosenblum, Hannah G., Shah, Melisa M., Twentyman, Evelyn, Meyer, Sarah, Peacock, Georgina, Thornburg, Natalie, Havers, Fiona P., Saydah, Sharon, Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Mahon, Barbara E., Daley, Matthew F., Fleming-Dutra, Katherine E., and Wallace, Megan

Subjects
United States. Food and Drug Administration, Pfizer Inc., Vaccination -- Usage, RNA -- Usage, Drug approval -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Health
Abstract

On October 10, 2023, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Introduction By the end of 2022, COVID-19 vaccines had prevented 18.5 million [...]

Published
2023

5. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices--United States, 2023

Author

Fleming-Dutra, Katherine E., Jones, Jefferson M., Roper, Lauren E., Prill, Mila M., Ortega-Sanchez, Ismael R., Moulia, Danielle L., Wallace, Megan, Godfrey, Monica, Broder, Karen R., Tepper, Naomi K., Brooks, Oliver, Sanchez, Pablo J., Kotton, Camille N., Mahon, Barbara E., Long, Sarah S., and McMorrow, Meredith L.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., AstraZeneca PLC, Sanofi S.A., Vaccination -- Usage, Diseases -- Prevention -- United States -- France -- United Kingdom, Infants -- Usage, Drug approval -- Usage, Epidemiology -- Usage, Vaccines -- Usage, Pregnant women -- Usage, Pharmaceutical industry -- Usage, Health, Abrysvo (Vaccine) -- Usage
Abstract

On October 6, 2023, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Introduction In August 2023, the Food and Drug Administration (FDA) approved RSVpreF [...]

Published
2023

6. Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines--United States, October 2022

Author

Rosenblum, Hannah G., Wallace, Megan, Godfrey, Monica, Roper, Lauren E., Hall, Elisha, Fleming-Dutra, Katherine E., Link-Gelles, Ruth, Pilishvili, Tamara, Williams, Jennifer, Moulia, Danielle L., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Daley, Matthew F., Meyer, Sarah, Oliver, Sara E., and Twentyman, Evelyn

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., Vaccination -- Usage, RNA -- Usage, Vaccines -- Usage, Health
Abstract

Four COVID-19 vaccines are currently approved for primary series vaccination in the United States under a Biologics License Application or authorized under an emergency use authorization (EUA) by the Food [...]

Published
2022

7. Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged [greater than or equal to] 18 years--United States, July 2022

Author

Twentyman, Evelyn, Wallace, Megan, Roper, Lauren E., Anderson, Tara C., Rubis, Amy B., Fleming-Dutra, Katherine E., Hall, Elisha, Hsu, Joy, Rosenblum, Hannah G., Godfrey, Monica, Archer, W. Roodly, Moulia, Danielle L., Daniel, Laura, Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Daley, Matthew, Meyer, Sarah, and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Vaccines -- Usage, Health
Abstract

The NVX-CoV2373 (Novavax) COVID-19 vaccine is a recombinant spike (rS) protein nanoparticle vaccine with Matrix-M adjuvant to protect against infection with SARS-CoV-2, the virus that causes COVID-19. On July 13, [...]

Published
2022

8. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years--United States, June 2022

Author

Fleming-Dutra, Katherine E., Wallace, Megan, Moulia, Danielle L., Twentyman, Evelyn, Roper, Lauren E., Hall, Elisha, Link-Gelles, Ruth, Godfrey, Monica, Woodworth, Kate R., Anderson, Tara C., Rubis, Amy B., Shanley, Edwin, III, Jones, Jefferson M., Morgan, Rebecca L., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Daley, Matthew, Meyer, Sarah, and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., Children's furniture -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Health
Abstract

On June 28, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). On June 17, 2022, the Food and Drug Administration (FDA) issued Emergency [...]

Published
2022

9. The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged [greater than or equal to]18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines--United States, February 2022

Author

Wallace, Megan, Moulia, Danielle, Blain, Amy E., Ricketts, Erin K., Minhaj, Faisal S., Link-Gelles, Ruth, Curran, Kathryn G., Hadler, Stephen C., Asif, Amimah, Godfrey, Monica, Hall, Elisha, Fiore, Anthony, Meyer, Sarah, Su, John R., Weintraub, Eric, Oster, Matthew E., Shimabukuro, Tom T., Campos- Outcalt, Doug, Morgan, Rebecca L., Bell, Beth P., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Daley, Matthew F., and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., Messenger RNA -- Usage -- Health aspects, Adults -- Health aspects -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Health aspects -- Usage, Health
Abstract

The mRNA-1273 (Moderna) COVID-19 vaccine is a lipid nanoparticle-encapsulated, nucleoside-modified mRNA vaccine encoding the stabilized prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. During December 2020, the vaccine [...]

Published
2022

10. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices--United States, December 2021

Author

Oliver, Sara E., Wallace, Megan, See, Isaac, Mbaeyi, Sarah, Godfrey, Monica, Hadler, Stephen C., Jatlaoui, Tara C., Twentyman, Evelyn, Hughes, Michelle M., Rao, Agam K., Flore, Anthony, Su, John R., Broder, Karen R., Shimabukuro, Tom, Lale, Allison, Shay, David K., Markowitz, Lauri E., Wharton, Melinda, Bell, Beth P., Brooks, Oliver, McNally, Veronica, Lee, Grace M., Talbot, H. Keipp, and Daley, Matthew F.

Subjects
United States. Food and Drug Administration, Johnson & Johnson, Vaccination -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Health
Abstract

On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the adenovirus-vectored COVID-19 vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, Johnson & [...]

Published
2022

11. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years--United States, November 2021

Author

Woodworth, Kate R., Moulia, Danielle, Collins, Jennifer P., Hadler, Stephen C., Jones, Jefferson M., Reddy, Sujan C., Chamberland, Mary, Campos-Outcalt, Doug, Morgan, Rebecca L., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Daley, Matthew F., Mbaeyi, Sarah, Dooling, Kathleen, and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, United States. Department of Health and Human Services, Pfizer Inc., Drug approval -- Usage, Vaccines -- Usage, Pharmaceutical industry -- Usage, Health
Abstract

On November 5, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). The Pfizer-BioNTech COVID-19 (BNT162b2) vaccine is a lipid nanoparticle--formulated, nucleoside-modified mRNA vaccine [...]

Published
2021

12. The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines--United States, 2021

Author

Mbaeyi, Sarah, Oliver, Sara E., Collins, Jennifer P., Godfrey, Monica, Goswami, Neela D., Hadler, Stephen C., Jones, Jefferson, Moline, Heidi, Moulia, Danielle, Reddy, Sujan, Schmit, Kristine, Wallace, Megan, Chamberland, Mary, Campos-Outcalt, Doug, Morgan, Rebecca L., Bell, Beth P., Brooks, Oliver, Kotton, Camille, Talbot, H. Keipp, Lee, Grace, Daley, Matthew F., and Dooling, Kathleen

Subjects
United States. Food and Drug Administration, Pfizer Inc., Vaccination, RNA, Vaccines, Pharmaceutical industry, Health
Abstract

On October 29, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Three COVID-19 vaccines are currently approved under a Biologics License Application (BLA) [...]

Published
2021

13. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged [greater than or equal to] 16 Years: Recommendations of the Advisory Committee on Immunization Practices--United States, September 2021

Author

Dooling, Kathleen, Gargano, Julia W., Moulia, Danielle, Wallace, Megan, Rosenblum, Hannah G., Blain, Amy E., Hadler, Stephen C., Plumb, Ian D., Moline, Heidi, Gerstein, Jack, Collins, Jennifer P., Godfrey, Monica, Campos-Outcalt, Doug, Morgan, Rebecca L., Brooks, Oliver, Talbot, H. Keipp, Lee, Grace M., Daley, Matthew F., and Oliver, Sara E.

Subjects
United States. Food and Drug Administration, Pfizer Inc., Vaccination -- Health aspects -- Usage, Medical colleges -- Health aspects -- Usage, Vaccines -- Usage, Health
Abstract

On September 21, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). The Pfizer-BioNTech COVID-19 vaccine (BNT162b2) is a lipid nanoparticle-formulated, nucleoside mRNA vaccine [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results